Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLM Chemotherapy in Elderly Metastatic Breast Cancer
NCT00010075Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Jan 2000
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mitoxantrone, fluorouracil and folinic acid in breast cancer, sponsored by GERCOR. Primary endpoint: Survival without degradation of quality of life. Status: unknown.
02
Drugs
mitoxantronefluorouracilfolinic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00010075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010075.